ID   FH39
AC   CVCL_E624
SY   TER315; TER-315; Ter 315; TER373; TER-373; Ter 373; TER472; TER-472; Ter 472
DR   dbMHC; 48813
DR   IHW; IHW09427
DR   IPD-IMGT/HLA; 26029
DR   Wikidata; Q54834827
RX   PubMed=30844424;
WW   http://pathology.ucla.edu/workfiles/366cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*26:01,34:01; B*07:06,40:01:01; C*03:04,07:02; DPB1*05:01,135:01; DQA1*01:02:01,01:04:01; DQB1*05:02:01,06:02; DRB1*11:05,15:02:01; DRB3*02:02:01; DRB5*01:02,01:08N (IPD-IMGT/HLA=26029).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//